// Chartbeat tag // Chartbeat tag

Bloodstream infection test wins FDA approval

Share this article:

The Food and Drug Administration approved a test Wednesday that can help physicians diagnose an infection and select the proper antibiotic much more rapidly than with existing tests.

The Verigene GP Blood Culture Nucleic Acid Test — which is known as the BC-GP test — can identify different types of Staphylococcus, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus, Enterococcus (including vancomycin-resistant Enterococci) and Listeria within hours of an infection starting, Medical News Today reports. Infectious diseases such as MRSA can devastate nursing homes.

Existing bacterial tests can take up to four days to culture, which can expose patients to higher risks and lessen the effectiveness of antibiotics. Treatment of an infection with the wrong antibiotic also can result in greater antibiotic resistance, experts warn. The new BC-GP test, made by Nanosphere, offers a leap forward in catching the disease early while evaluating antibiotic resistance, the company's CEO told Medical News Today.

Share this article:

More in News

ACO bill in House would waive 3-midnight requirement for skilled nursing care

Certain Accountable Care Organizations would be able to send Medicare beneficiaries to a skilled nursing facility without a prior hospital stay under a bipartisan bill recently introduced in the House of Representatives.

Increasing staff-to-patient ratios improves nurse safety, researchers find

A law setting mandatory nurse-to-patient staffing ratios has reduced the number of workplace injuries for registered nurses and licensed practical nurses in California, according to recently published findings.

Life Care Centers takes Gold in Transitions category

Life Care Centers takes Gold in Transitions category

Life Care Centers of America has won the Gold Award in the McKnight's Excellence in Technology Awards in the Transitions category.